The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 13.8% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 12% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 25%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (2 analysts) rates it buy, with a mean price target of $33.
Manulife Financial Corporation MFC
Outside both standards
An entry written while the outcome is still unknown. It will be scored by what the market does next, and it will never be edited to look cleverer than it was.
In plain words · Manulife Financial Corporation, together with its subsidiaries, provides financial products and services in the United States, Canada, Asia, and internationally.
read at $44.45
Manulife Financial Corporation holds its Markup at $44.45.
- PHPhase · the trend structure carries the Markup label
- INInsiders · no filings inside 60 days, left as found
- POPositioning · no disclosures inside 60 days, left as found
- OPOptions · no verdict drawn today, left as found
- SCScreen · does not pass the values gate
- edge confirmed
- edge broken
- edge forming
Each arm is one independent read. Conviction is not a single call, it is how many edges converge.
The investor read · the season, not the day
| Phase | Markup |
| Quantitative state | Consolidating, no directional conviction, held for 261 days |
| Price | $44.45 |
| Valuation | 17.92 trailing · 12.71 forward price to earnings |
| Values screen | FAIL · score 10.0 |
| Beta | 0.78 |
The opportunity · what the numbers say it is worth
Our framework reads AVOID — it trades above our $37.16 fair value estimate, moderate competitive moat, 12.10% revenue growth.
Price history & projections · where it has been, where the models see it going
The valuation journey · where the price sits against fair value and the Street
Green marks levels above today's price, red below; the shaded band is the gap between the price and our fair value.
Reading the gap · Both our model and the Street see limited upside at this price.
| Revenue growth | 12.10% |
| Profit margin | 20.04% |
| Debt to equity | 44.28 |
| Analyst consensus | Buy · 2 covering |
Fair value and rating are our own model estimates; target range reflects third-party analyst estimates. Analysis, not advice.
The values screen, explained · five checks, plain English
This company is excluded by both standards. There are two widely recognised ways to check whether a company is suitable for a Muslim investor. It fails on both:
Used by most halal investing apps ✗ DOES NOT PASS
The one Titan applies ✗ DOES NOT PASS
Why it fails. The problem is its business activity. Because both standards agree on this, it is a clear exclusion, not a borderline case.
What these two standards are, and how they differ →
- Business activity Financial sector: insurance Fail
- Debt load Interest-bearing debt is just 0.0% of its assets, well under the one-third ceiling — it does not run on borrowed money. Pass
- Interest-bearing cash Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit. Pass
- Receivables Money owed to the company is 0.0% of assets, under the 49% limit. Pass
- Revenue purity Only 0.0% of revenue comes from non-compliant sources — under the 5% line. Pass
Every security is read against two recognised standards: our stricter asset-based screen (ratios measured against total assets) and the more widely used market-value standard (measured against market capitalisation). Where they agree we say so plainly; where they part ways — almost always on the debt check — we show both readings and mark it, because that disagreement is the finding, not a fault. We report the score; you and your scholar make the call.
The business, in plain words · what the numbers mean
Ethical screen rules out Manulife at any price
Every month families in Toronto or Singapore pay premiums hoping the insurer will be there when life turns hard. Manulife clears the usual financial hurdles yet fails our ethical screen on core business activity, so we pass.
Revenue is rising 12 percent and margins sit at 20 percent, but the shares trade above our fair value of 37.13 dollars with only a moderate moat. The 12.4 times forward earnings multiple looks ordinary rather than cheap once that ethical flag is raised.
Interest-rate swings and long-term claims risk remain real, yet the decisive issue stays the screen result. Analysis, not advice.
| Forward P/E | 12.7x fairly priced for its growth rate |
| Trailing P/E | 17.9x reasonably valued |
| Revenue growth | 12.1% steady growth |
| Profit margin | 20.0% healthy profit margins |
| Return on equity | 12.6% a solid return on shareholder capital |
| Debt to equity | 0.44 minimal debt — a conservative balance sheet |
| Current ratio | 30.14 comfortably covers its short-term bills |
| Beta | 0.78 steadier than the market |
| Market cap | $74.0B |
| Employees | 37,000 |
The risks · The things to watch: its business and earnings are exposed to Canada and to currency swings.
Plain-English interpretation of our own screen data. Analysis, not advice.
Latest news · what the market is reading on MFC
- › MFC Outperforms Industry, Hits 52-Week High: How to Play the Stock Zacks · 14 Jul 2026
- › RGA Outperforms Industry, Trades at a Discount: Time to Hold? Zacks · 29 Jun 2026
- › BHF Outperforms the Industry: Operational Momentum Continues Zacks · 25 Jun 2026
- › SLF Stock Hits 52-Week High: Time to Hold Despite Expensive Valuation? Zacks · 24 Jun 2026
- › Manulife (TSX:MFC) Launches Protection VUL Through John Hancock With Vitality Rewards Simply Wall St. · 23 Jun 2026
Headlines from third-party outlets, linked for reference — not our reporting, not advice.
Related securities · others in MFC's space worth a look
Screened names in the same industry · explore each on its own page.
Where & how to trade · wherever in the world you are
MFC trades on the NYSE (the company is based in Canada). As a US-listed security it is accessible through almost any international broker offering US markets. New to this, or investing from outside the US? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The trader read · the latest dated commentary
The dated journal · newest first, never edited
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 12% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 25%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (2 analysts) rates it buy, with a mean price target of $33.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
The insider ledger · Form 4 filings, as filed
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-19 | Kreel (Trevor) | Senior Officer of Issuer | 2,661 | $47,647 | |
| 2026-05-19 | Kreel (Trevor) | Senior Officer of Issuer | 2,661 | $100,737 | |
| 2026-05-19 | Fadous (Stephanie) | Senior Officer of Issuer | 2,661 | $47,647 | |
| 2026-05-19 | Fadous (Stephanie) | Senior Officer of Issuer | 2,661 | $100,737 | |
| 2026-05-19 | Tingle (Brooks) | Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) | 3,931 | $70,388 | |
| 2026-05-19 | Tingle (Brooks) | Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) | 3,931 | $148,815 | |
| 2026-04-30 | Manulife Financial Corporation | Issuer | 170,000 | $6,648,360 | |
| 2026-04-30 | Manulife Financial Corporation | Issuer | 3,670,400 | · | |
| 2026-04-29 | Manulife Financial Corporation | Issuer | 170,000 | $6,532,250 | |
| 2026-04-28 | Manulife Financial Corporation | Issuer | 170,000 | $6,574,070 |
Public filings, recorded as found. The full tape lives at Insider Intelligence.
What holding actually paid · price plus dividends
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $39.60 | -0.6% | $0.35 | $1,003 | +0.3% |
| 2 months | $36.18 | +8.8% | $0.35 | $1,097 | +9.7% |
| 3 months | $33.19 | +18.6% | $0.35 | $1,196 | +19.6% |
| 6 months | $34.97 | +12.5% | $0.71 | $1,145 | +14.5% |
| 1 year | $31.44 | +25.2% | $0.71 | $1,274 | +27.4% |
| 2 years | $24.71 | +59.2% | $1.91 | $1,670 | +67.0% |
| 3 years | $17.20 | +128.8% | $3.04 | $2,464 | +146.4% |
| 5 years | $16.33 | +141.0% | $5.08 | $2,721 | +172.1% |
Historical returns from market close data. Past performance does not guarantee future results.